文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

美国去甲肾上腺素短缺与脓毒性休克患者死亡率之间的关联

Association Between US Norepinephrine Shortage and Mortality Among Patients With Septic Shock.
PubMed 文献 · JAMA · 2017-01-01
一句话结论2011年美国去甲肾上腺素短缺期间,脓毒性休克患者住院死亡率升高(39.6% vs 35.9%,绝对风险增加3.7%),去甲肾上腺素使用率从77.0%降至55.7%。

该回顾性队列研究纳入美国26家医院2008年7月1日至2013年6月30日收治的27835例脓毒性休克成人患者,评估2011年全国去甲肾上腺素短缺对替代血管加压药使用及住院死亡率的影响。短缺季度去甲肾上腺素使用率从短缺前77.0%降至2011年第二季度最低55.7%,去氧肾上腺素成为最常用替代药(基线36.2%,最高54.4%)。短缺季度入院患者住院死亡率为39.6%(777/1961),非短缺季度为35.9%(9283/25874),绝对风险增加3.7%(95%CI 1.5%-6.0%),校正OR=1.15(95%CI 1.01-1.30;P=0.03)。作者认为去甲肾上腺素短缺与脓毒性休克患者住院死亡率升高相关。

要点

  • 短缺季度入院脓毒性休克患者住院死亡率39.6%(777/1961)vs 非短缺季度35.9%(9283/25874),绝对风险增加3.7%(95%CI 1.5%-6.0%)。
  • 校正后短缺季度入院与住院死亡率升高相关(校正OR=1.15,95%CI 1.01-1.30;P=0.03)。
  • 短缺期间去甲肾上腺素使用率从77.0%(95%CI 76.2%-77.8%)降至2011年第二季度最低55.7%(95%CI 52.0%-58.4%)。
  • 去氧肾上腺素为短缺期间最常用替代血管加压药,使用率从基线36.2%(95%CI 35.3%-37.1%)升至最高54.4%(95%CI 51.8%-57.2%)。
  • 研究纳入26家美国医院基线去甲肾上腺素使用率≥60%的脓毒性休克成人患者,短缺定义为2011年任一3个月季度医院去甲肾上腺素使用率较基线下降超过20%。

适用人群与场景

  • 美国26家医院收治的脓毒性休克成人患者,医院基线去甲肾上腺素使用率至少60%,纳入时间为2008年7月1日至2013年6月30日(n=27835)。
  • 中位年龄69岁(四分位距57-79岁),女性占47.0%。

诊断标准与关键阈值

  • 医院层面去甲肾上腺素短缺定义为2011年任一3个月季度医院去甲肾上腺素使用率较基线下降超过20%。

研究设计与关键结果

  • 回顾性队列研究,纳入美国26家医院27835例脓毒性休克成人患者,比较短缺季度与非短缺季度入院患者的住院死亡率。
  • 去甲肾上腺素使用率从短缺前77.0%(95%CI 76.2%-77.8%)降至2011年第二季度最低55.7%(95%CI 52.0%-58.4%);去氧肾上腺素使用率从基线36.2%(95%CI 35.3%-37.1%)升至最高54.4%(95%CI 51.8%-57.2%)。
  • 短缺季度入院患者住院死亡率39.6%(777/1961)vs 非短缺季度35.9%(9283/25874),绝对风险增加3.7%(95%CI 1.5%-6.0%),校正OR=1.15(95%CI 1.01-1.30;P=0.03)。

证据类型、等级与局限

  • 证据类型:回顾性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,在美国受2011年去甲肾上腺素短缺影响的医院中,脓毒性休克患者最常使用的替代血管加压药是去氧肾上腺素;短缺期间入院的患者住院死亡率更高。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: Drug shortages in the United States are common, but their effect on patient care and outcomes has rarely been reported.

OBJECTIVE: To assess changes to patient care and outcomes associated with a 2011 national shortage of norepinephrine, the first-line vasopressor for septic shock.

DESIGN, SETTING, AND PARTICIPANTS: Retrospective cohort study of 26 US hospitals in the Premier Healthcare Database with a baseline rate of norepinephrine use of at least 60% for patients with septic shock. The cohort included adults with septic shock admitted to study hospitals between July 1, 2008, and June 30, 2013 (n = 27 835).

EXPOSURES: Hospital-level norepinephrine shortage was defined as any quarterly (3-month) interval in 2011 during which the hospital rate of norepinephrine use decreased by more than 20% from baseline.

MAIN OUTCOMES AND MEASURES: Use of alternative vasopressors was assessed and a multilevel mixed-effects logistic regression model was used to evaluate the association between admission to a hospital during a norepinephrine shortage quarter and in-hospital mortality.

RESULTS: Among 27 835 patients (median age, 69 years [interquartile range, 57-79 years]; 47.0% women) with septic shock in 26 hospitals that demonstrated at least 1 quarter of norepinephrine shortage in 2011, norepinephrine use among cohort patients declined from 77.0% (95% CI, 76.2%-77.8%) of patients before the shortage to a low of 55.7% (95% CI, 52.0%-58.4%) in the second quarter of 2011; phenylephrine was the most frequently used alternative vasopressor during this time (baseline, 36.2% [95% CI, 35.3%-37.1%]; maximum, 54.4% [95% CI, 51.8%-57.2%]). Compared with hospital admission with septic shock during quarters of normal use, hospital admission during quarters of shortage was associated with an increased rate of in-hospital mortality (9283 of 25 874 patients [35.9%] vs 777 of 1961 patients [39.6%], respectively; absolute risk increase = 3.7% [95% CI, 1.5%-6.0%]; adjusted odds ratio = 1.15 [95% CI, 1.01-1.30]; P = .03).

CONCLUSIONS AND RELEVANCE: Among patients with septic shock in US hospitals affected by the 2011 norepinephrine shortage, the most commonly administered alternative vasopressor was phenylephrine. Patients admitted to these hospitals during times of shortage had higher in-hospital mortality.

来源:JAMA,查看原文。版权归原作者所有。

参考来源

  1. Vail E, Gershengorn HB, Hua M, et al. Association Between US Norepinephrine Shortage and Mortality Among Patients With Septic Shock. JAMA. 2017. PMID: 28322415. doi:10.1001/jama.2017.2841

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。